Locations:
SearchAdvertisement
Unraveling the TNFA receptor 2/dendritic cell axis
Husni Lab focuses on transforming management and treatment
E-coaching program is tailored for those with the disease
Sustained efficacy and safety
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Defect in myosin binding may explain why a significant percentage of patients do not adequately respond to anti-TNF therapy
Study assesses utility of patient-reported outcomes measures in uveitis and scleritis
Husni lab recently funded by NIH-NIAMS
New long-term outcomes data offer insights
Evaluating PROs in immune-mediated diseases
A practical PRO biomarker databank
Advertisement
Advertisement